The Soviet Tonometer competitive landscape is fragmented; no single vendor holds double-digit share, and the market is split between a handful of global ophthalmic incumbents and a diffuse cohort of regional OEMs that assemble low-cost contact and non-contact units. Price, rather than clinical evidence, remains the primary procurement lever for district hospitals and primary-care clinics, while tertiary centres weigh service contracts, calibration cycles, and post-sale traceability. Global suppliers secure share by bundling tonometers with existing slit-lamp or perimeter platforms, leveraging established service footprints and mandatory GOST-R and EAEU registrations. Local producers counter with shorter lead times, domestic language interfaces, and 30โ40 % lower list pricing, but frequently sacrifice margin to offset higher component import duties and limited access to gold-standard calibration fluids.